<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04718246</url>
  </required_header>
  <id_info>
    <org_study_id>Maie2</org_study_id>
    <nct_id>NCT04718246</nct_id>
  </id_info>
  <brief_title>Stability Of Dental Implants Placed In Healed Bony Sites Of Hyperlipidemic Patients: A Case Series</brief_title>
  <official_title>Stability Of Dental Implants Placed In Healed Bony Sites Of Hyperlipidemic Patients: A Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Statement of the problem:&#xD;
&#xD;
      Osseo-integration of dental implants depends mainly on bone regeneration around dental&#xD;
      implant. Hyperlipidemia has significant adverse effects on bone health, leading to lower bone&#xD;
      mineral density and to higher risk of osteoporosis and bone fracture (Corwin 2003; Pirih, Lu&#xD;
      et al. 2012). The effects of hyperlipidemia on bone health may also interfere with dental&#xD;
      implant therapy since the host's bone quantity, quality and healing potential play an&#xD;
      important role in osseointegration (Fedele, Sabbah et al. 2011; Gaetti-Jardim,&#xD;
      Santiago-Junior et al. 2011; Olivares-Navarrete, Raines et al. 2012).&#xD;
&#xD;
      Rationale for conducting the research:&#xD;
&#xD;
      Hyperlipidemia has been associated with the pathophysiology of major diseases, such as&#xD;
      atherosclerosis and osteoporosis.&#xD;
&#xD;
      A high cholesterol level has significant adverse effects on bone, including lower bone&#xD;
      density, volume and strength. Statins, drugs that lower serum cholesterol levels have&#xD;
      beneficial effects on bone metabolism. Since host's bone quantity, quality and healing&#xD;
      potential play a crucial role in osseointegration of dental implants, it was hypothesized&#xD;
      that hyperlipidemia may negatively affect implant osseointegration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The high predictability of dental implants has led to routine use with a great expectation&#xD;
      for success. There are many researches focused on the outcome of delayed dental implant.&#xD;
      Since the first report of highly success rate after placement of a dental implant, there has&#xD;
      been increasing interest in this technique for implant treatment (Chen ST., 2004) The goal of&#xD;
      modern dentistry is to restore the patient's dentition to normal contour, function, comfort,&#xD;
      esthetics, speech and health regardless of the atrophy, disease or injury of the&#xD;
      stomatognathic system, as a result of disease related tooth loss and the value placed upon&#xD;
      teeth, there has been a continual search for methods by which missing teeth could be&#xD;
      replaced. Early artificial replacements were made from natural teeth and a variety of&#xD;
      substitute materials. All transplantation of a tooth from one person to another was an early&#xD;
      method by which lost teeth were replaced. Archeological discoveries indicate that many&#xD;
      ancient civilizations practiced allogenic tooth transplantation. In 1561, Ambrose Pare&#xD;
      reported that decayed teeth could be replaced by using extracted teeth from another&#xD;
      individual and is credited with being the first to mention transplantation (Chiu YW., 2015)&#xD;
      Periimplant osteogenesis consists of postsurgical reaction and remodeling of the bone and the&#xD;
      initiation and progression of de novo bone formation, which are represented as a reduction in&#xD;
      primary stability and development of secondary stability, respectively (Ogawa and Nishimura,&#xD;
      2003, Aparicio et al., 2006, Atsumi et al., 2007). Dental implant survival is mainly&#xD;
      dependent on successful osseointegration following placement. Any alteration of this&#xD;
      biological process may adversely affect the success rate. Also, the long-term prognosis is&#xD;
      adversely affected by inadequate bone volume at implant sites. There are several risk factors&#xD;
      that were defined as implant failure. One of the risks of implant's failure depends on the&#xD;
      systemic health of the subject (such as diabetes mellitus, osteoporosis, smoking) Recently,&#xD;
      some authors suggested that there is a relationship between hypercholesterolemia and dental&#xD;
      implant osseointegration (Keuroghlian A et al.. 2015, Tirone F et al. 2016). Hyperlipidemia&#xD;
      is a state with an abnormal lipid pro- file, which is characterized by elevated blood&#xD;
      concentrations of triglycerides, elevated levels of total cholesterol and LDL, and decreased&#xD;
      levels of HDL cholesterol ( Saxlin T., 2008) Hyperlipidemia is associated with several&#xD;
      diseases such as atherosclerosis and osteoporosis. The National Health and Nutrition&#xD;
      Examination Survey (NHANES III) reported that 63% of osteoporotic patients have&#xD;
      hyperlipidemia (Bilezikian JP., 2005) The main mechanisms of the relationship between&#xD;
      hyperlipidemia and bone tissue metabolism are the involved aspects of some metabolic changes,&#xD;
      including lower bone mineral density, increase in the number of osteoclasts, and the&#xD;
      inhibition of osteoblastic activity. However, several investigators suggested that lipid-&#xD;
      lowering drugs, such as statins, had beneficial effects on bone metabolism and also favorable&#xD;
      effects on statins observed on osteogenesis around implants (Moriyama Y et al., 2010).&#xD;
      Recently many papers focused on High cholesterol and its impact effect on bone turn over&#xD;
      around dental implant but all of them are animal studies. Mish (2008) defined four bone&#xD;
      density groups (D1 to D4) found in all jaw regions varying according to macroscopic cortical&#xD;
      and trabecular bone types. D1 is dense and homogenous type of bone that is often found in&#xD;
      anterior mandibles. D2 is a combination of dense-to-porous cortical bone on the crest and&#xD;
      coarse trabecular bone on the inside. D3 is composed of thinner porous cortical bone on the&#xD;
      crest and fine trabecule. Mish (2008) defined four bone density groups (D1 to D4) found in&#xD;
      all jaw regions varying according to macroscopic cortical and trabecular bone types. D1 is&#xD;
      dense and homogenous type of bone that is often found in anterior mandibles. D2 is a&#xD;
      combination of dense-to-porous cortical bone on the crest and coarse trabecular bone on the&#xD;
      inside. D3 is composed of thinner porous cortical bone on the crest and fine trabecular bone&#xD;
      within the ridge. The D2 bone trabeculae are 40% to 60% stronger than D3 trabeculae. D4 bone&#xD;
      has very little density and little or no cortical crestal bone. It is the opposite of D1. The&#xD;
      most common locations for D4 type of bone are the posterior region of the maxilla. D4 bone&#xD;
      trabeculae may be up to 10 times weaker than the cortical bone of D1 and the bone-implant&#xD;
      contact after initial loading is often less than 25%. Bone trabeculae are sparse and, as a&#xD;
      result, initial fixation of any implant design presents a surgical challenge (Dvorak G.,&#xD;
      2011) Primary or secondary implant stability usually measured by Periotest or Ostell,&#xD;
      Periotest measuring procedure is electromechanical. An electrically driven and electronically&#xD;
      monitored tapping head percusses the implant 16 times. The entire measuring procedure&#xD;
      requires approx. 4 seconds. The tapping head is pressure sensitive and records the duration&#xD;
      of contact with the test object. Loose implants display a longer contact time and the&#xD;
      Periotest values are correspondingly higher, while osseointegrated implants have a short&#xD;
      contact time and result in low Periotest values. Periotest values (PTV) of (-8 to +50) were&#xD;
      -ve values considered the ideal values that denote successful osseointegration (Molly L.,&#xD;
      2006). Although the ever-increasing number of published animal studies on this topic, there&#xD;
      is however no consensus regarding dental implants stability in patients with hyperlipidemia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant stability</measure>
    <time_frame>At time of implant placement, 6 months post-implant placement</time_frame>
    <description>Outcome will be determined using sonance frequency analysis (RFA) (Osstell) periotest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Measured 7 and 14 days post-implant placement</time_frame>
    <description>Measured using Numerical Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swelling</measure>
    <time_frame>7 days post-implant placement</time_frame>
    <description>Measured using verbal rating scale, categorized as either (VRS) Absent-slight-moderate- Or intense</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crestal bone level</measure>
    <time_frame>Same day as implant placement, 3 and 6 months post-implant.</time_frame>
    <description>Digital periapical radiograph using a radiographic holder and an acrylic radiographic stent -which is constructed previously on patient's cast= will be taken to determine the crestal bone level and resorption. The parallel technique in combination with the acrylic stent is performed to ensure reproducibility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osseointegration</measure>
    <time_frame>Same day as implant placement, 3 and 6 months post-implant.</time_frame>
    <description>Digital periapical radiograph using a radiographic holder and an acrylic radiographic stent -which is constructed previously on patient's cast= will be taken to determine the crestal bone level and resorption. The parallel technique in combination with the acrylic stent is performed to ensure reproducibility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survival</measure>
    <time_frame>6 months post-implant placement</time_frame>
    <description>Assessed as a dicotomous outcome (Yes/No)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Implant Stability</condition>
  <arm_group>
    <arm_group_label>Dental Implants in hyperlipidemia patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implants will be placed at T0, then Implant site exposure will take place 6 months following the implant placement. Insertion of the healing collars in order to obtain adequate soft tissue form for 1-2 weeks then the impressions (indirect, closed tray echnique) shall be taken to fabricate the final crowns, then the final crowns will be fitted in place.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dental Implants Placed In hyperlipidemia patients</intervention_name>
    <description>A preoperative cone beam CT (CBCT) will be performed for each patient prior to the surgery.&#xD;
Surgical phase (T0):&#xD;
After local anesthetics, all osteotomies will be prepared by the same operator, using a drilling speed of 1200 rpm, under copious irrigation with normal saline.&#xD;
Penetration of cortical bone will be achieved with no. 6 round burs.&#xD;
The osteotomies will be widened, using a drill 1 mm larger than the final drill provided by the manufacturer. The final size of the control osteotomies were same diameter of the implant.&#xD;
PeriotestÂ® will measure initial implant stability. Implant site exposure will take place 6 months following the implant placement. Insertion of the healing collars in order to obtain adequate soft tissue form for 1-2 weeks</description>
    <arm_group_label>Dental Implants in hyperlipidemia patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who have at least one missing tooth.&#xD;
&#xD;
          -  Patient with hyperlipidemia (LDL &lt; 160 mg/dl )&#xD;
&#xD;
          -  Patients with sufficient interarch space.&#xD;
&#xD;
          -  Patients aged from 20 to 60 years old.&#xD;
&#xD;
          -  Good oral hygiene.(Wiesner et al. 2010)&#xD;
&#xD;
          -  Accepts 6 months follow-up period (cooperative patients)&#xD;
&#xD;
          -  Patient provides an informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with signs of acute infection related to the area of interest.&#xD;
&#xD;
          -  Patients with habits that may jeopardize the implant longevity and affect the results&#xD;
             of the study such as parafunctional habits (Lobbezoo et al. 2006).&#xD;
&#xD;
          -  Current and former smokers (Lambert et al, 2000)&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Psychological problems -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amr Zahran, PhD</last_name>
    <phone>+20 120 000 6635</phone>
    <email>amr.zahran@dentistry.cu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry - Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr Zahran, PhD</last_name>
      <email>amr.zahran@dentistry.cu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 17, 2021</study_first_submitted>
  <study_first_submitted_qc>January 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 17, 2021</last_update_submitted>
  <last_update_submitted_qc>January 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Maie Ismaiel mohammed Fathy</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Hyperlipidemia</keyword>
  <keyword>Implant survival</keyword>
  <keyword>osseointegration</keyword>
  <keyword>CBCT</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

